Member
Core Members
 |
Hideki Tanzawa | Professor and Chairman‚ Department of Clinical Molecular Biology‚ Graduate School of Medicine‚ Chiba University |
|---|
Research title: Development of new effective radiotherapy and chemotherapy‚ that is compatible with cancer immunotherapy.
This project develops new methods and medicines for the effective radiotherapy and chemotherapy‚ compatible with cancer immunotherapy. Our research group will reveal the genes and pathways related to drug-resistance and radio-resistance in the cancer. Moreover‚ several chemical agents inhibiting the drug-resistant genes and/or radio-resistant genes will be identified and translational research to conquer the resistance will be performed in vitro and in vivo using these chemical agents for clinical use. This project also provides an educational program for specialists in research and the treatment of cancer.
